Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Strategic Partners ASOCSE:STRAP 29 Equity-to-Asset is 0.94 as of Dec. 2025, which is 25% above its 10-year median of 0.75. GuruFocus rates OCSE:STRAP with a GF Score™ of 29/100. The stock has 2 warning signs investors should review. Among 1,417 Biotechnology companies, Strategic Partners AS ranks better than 91.88% on this metric.
Strategic Partners AS (OCSE:STRAP) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Strategic Partners AS Equity-to-Asset Related Terms
Strategic Partners AS Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Strategic Partners AS's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:STRAP vs VRTX, REGN, RVMD: Equity-to-Asset Comparison
For the Biotechnology subindustry, Strategic Partners AS's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strategic Partners AS Equity-to-Asset vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Strategic Partners AS's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Strategic Partners AS's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Strategic Partners AS's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Strategic Partners AS (OCSE:STRAP) has a Equity-to-Asset of 0.94 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Strategic Partners AS and its competitors. This is 25% above median its historical median of 0.75. Over the past decade, Strategic Partners AS's Equity-to-Asset has ranged from 0.05 to 0.94. According to the industry distribution chart, Strategic Partners AS ranks #115 out of 1417 companies in the Biotechnology industry, placing it in the top 8.1%.
Is Strategic Partners AS's Equity-to-Asset too high?
Strategic Partners AS's current Equity-to-Asset of 0.94 is 25% above median its 10-year median of 0.75. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 0.94. The Biotechnology industry median Equity-to-Asset is 0.68. Strategic Partners AS's value of 0.94 is 38.2% above this industry median. Based on the distribution chart, Strategic Partners AS ranks #115 out of 1417 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Strategic Partners AS has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Strategic Partners AS's Equity-to-Asset compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Strategic Partners AS ranks #115 out of 1417 companies for Equity-to-Asset. This places Strategic Partners AS in the top 8% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.68. Strategic Partners AS's value of 0.94 is 38.2% above this benchmark. Historically, Strategic Partners AS's own Equity-to-Asset has ranged from 0.05 to 0.94 over the past decade. While the company's 10-year median is 0.75 vs. the industry median of 0.68, Strategic Partners AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Biotechnology company?
The median Equity-to-Asset among Biotechnology companies is 0.68, based on 1,417 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Strategic Partners AS's current Equity-to-Asset of 0.94 is 38.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Strategic Partners AS and its competitors. For the Biotechnology industry, the median Equity-to-Asset is 0.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strategic Partners AS's current Equity-to-Asset is 0.94, which is 25% above median its own 10-year median of 0.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strategic Partners AS stock overvalued right now?
Strategic Partners AS (OCSE:STRAP) has a current Equity-to-Asset of 0.94. The current Equity-to-Asset is 0.94, which is 25% above median its 10-year median of 0.75 and 38.2% above the Biotechnology industry median of 0.68. Strategic Partners AS's overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Strategic Partners AS (OCSE:STRAP), the current Equity-to-Asset is 0.94 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Strategic Partners A/S enters into strategic partnerships with companies with potential, where the company can take an active ownership and create value through its competencies. Additionally, the company takes part in other equity investments and properties, etc., to generate returns.
29GF Score
Get the complete analysis for OCSE:STRAP
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:STRAP has been successfully added to your 
